Recognition of lipopolysaccharide (LPS) by Toll-like receptor (TLR)4 initiates an intracellular signaling pathway leading to the activation of nuclear factor-B (NF-B). Although LPS-induced activation of NF-B isThe innate immune response to microbial pathogens begins when pathogen-associated molecular patterns meet their cognate Toll-like receptors (TLRs) 8 on effector cells of the immune system, such as monocytes and macrophages (1). Lipopolysaccharide (LPS), an integral cell wall component of Gram-negative bacteria and one of the most potent stimulators in innate immunity, is recognized by the TLR4-MD2 receptor complex (2). In the past years, much progress has been made in understanding the intracellular signaling cascades that are initiated when LPS stimulates TLR4 (reviewed in Refs. 3 and 4). Ligation of the TLR4-MD2 complex by LPS initially results in the recruitment of myeloid differentiation factor (MyD)88 and MyD88-adaptor like (Mal), also called TIRAP, to the receptor cytoplasmic domain. MyD88 then facilitates recruitment of the serine/threonine kinases IL-1R-associated kinase (IRAK)-1 and -4, thus enabling IRAK4 to phosphorylate IRAK1. The latter subsequently dissociates from the receptor complex and associates with tumor necrosis factor (TNF) receptor-associated factor (TRAF)6, constituting a cytoplasmic signaling complex. Upon ubiquitination, TRAF6 activates transforming growth factor-â€-activated kinase 1, which in turn activates the inhibitor of B kinase (IKK) complex that consists of the regulatory subunit IKKâ„ (also known as NEMO) and the kinases IKK⣠and IKKâ€. The latter eventually phosphorylates the inhibitory IB proteins, resulting in their ubiquitination and degradation. This allows the transcription factor NF-B to translocate to the nucleus and initiate transcription of inflammatory cytokines, such as TNF, which contribute to mounting an inflammatory response. Apart from this MyD88-dependent signaling pathway, TLR4 also initiates a MyD88-independent signaling pathway that is mediated by the adaptor proteins Toll/IL-1 receptor domain domain-containing adaptor-inducing interferon-†(TRIF; also known as TICAM-1) and TRIFrelated adaptor molecule (also known as TICAM-2). Although